COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
The conflict is also triggering a widening public health emergency
The order will cover the manufacturing of bulk vaccine in 2026
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The move is expected to be crucial during health crises
Subscribe To Our Newsletter & Stay Updated
